AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Business Wire
Fourth Quarter 2025 worldwide revenue of $140.5 million – an increase of 13.1% year over yearFourth Quarter 2025 net income of $1.8 million and positive adjusted EBITDA of $19.9 millionFull Year 2025 worldwide revenue of $534.5 million – an increase of 14.9% year over yearFull Year 2025 net loss of $11.4 million and positive adjusted EBITDA of $61.8 million2025 growth marked by expanding use of new products, including cryoSPHERE® MAX™ and AtriClip FLEX-Mini®, and the continued adoption of EnCompass® clamp MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2025 and full year 2025 financial results.“Our 2025 performance reflects strong execution and continued momentum in our business. We delivered 15% revenue growth for the year and strengthened profitability while advancing key inn
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- AtriCure (NASDAQ:ATRC) was given a new $53.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG.MarketBeat
- AtriCure (NASDAQ:ATRC) had its price target lowered by analysts at Citizens Jmp from $60.00 to $52.00. They now have a "market outperform" rating on the stock.MarketBeat
- AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.MarketBeat
ATRC
Earnings
- 2/17/26 - Beat
ATRC
Sec Filings
- 2/19/26 - Form 10-K
- 2/17/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- ATRC's page on the SEC website